Financial Perspectives’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Hold |
1,864
| – | – | 0.04% | 197 |
|
|
2025
Q1 | $137K | Buy |
1,864
+1
| +0.1% | +$74 | 0.05% | 177 |
|
|
2024
Q4 | $122K | Buy |
1,863
+78
| +4% | +$5.11K | 0.04% | 196 |
|
|
2024
Q3 | $139K | Hold |
1,785
| – | – | 0.05% | 174 |
|
|
2024
Q2 | $139K | Hold |
1,785
| – | – | 0.05% | 169 |
|
|
2024
Q1 | $121K | Buy |
1,785
+1
| +0.1% | +$68 | 0.05% | 182 |
|
|
2023
Q4 | $120K | Buy |
1,784
+340
| +24% | +$22.9K | 0.05% | 180 |
|
|
2023
Q3 | $97.8K | Buy |
1,444
+148
| +11% | +$10K | 0.04% | 188 |
|
|
2023
Q2 | $92.8K | Hold |
1,296
| – | – | 0.04% | 203 |
|
|
2023
Q1 | $90K | Buy |
1,296
+50
| +4% | +$3.47K | 0.04% | 195 |
|
|
2022
Q4 | $84.5K | Hold |
1,246
| – | – | 0.04% | 194 |
|
|
2022
Q3 | $68.3K | Hold |
1,246
| – | – | 0.04% | 208 |
|
|
2022
Q2 | $82.3K | Hold |
1,246
| – | – | 0.05% | 188 |
|
|
2022
Q1 | $82.6K | Hold |
1,246
| – | – | 0.04% | 207 |
|
|
2021
Q4 | $72.6K | Buy |
1,246
+1,226
| +6,130% | +$71.4K | 0.03% | 205 |
|
|
2021
Q3 | $1.17K | Sell |
20
-6,149
| -100% | -$360K | ﹤0.01% | 613 |
|
|
2021
Q2 | $370K | Sell |
6,169
-300,571
| -98% | -$18M | 0.18% | 85 |
|
|
2021
Q1 | $6.17M | Buy |
306,740
+300,571
| +4,872% | +$6.04M | 0.31% | 60 |
|
|
2020
Q4 | $308K | Buy |
6,169
+19
| +0.3% | +$950 | 0.18% | 84 |
|
|
2020
Q3 | $337K | Hold |
6,150
| – | – | 0.22% | 63 |
|
|
2020
Q2 | $325K | Hold |
6,150
| – | – | 0.23% | 63 |
|
|
2020
Q1 | $275K | Hold |
6,150
| – | – | 0.22% | 59 |
|
|
2019
Q4 | $307K | Buy |
+6,150
| New | +$307K | 0.21% | 61 |
|